Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix: Report of Two Cases With Literature Review.

Cervical carcinoma is the second most common female malignancy worldwide. It usually spreads by direct local extension or the lymphatic vessels. Hematogenous dissemination with distant skeletal muscle metastases is a rare phenomenon.

Concurrent chemoradiation for cervical cancer: results of five randomized trials.

Background: Cervical cancer is the second most common cancer among women's in Bosnia and Herzegovina. Most of these women's in the time of diagnosis are with advanced disease. In the 1999 NCI issued a clinical alert, recommending that chemo radiation should be implemented as new treatment for these patients.

Ex vivo rapamycin generates apoptosis-resistant donor Th2 cells that persist in vivo and prevent hemopoietic stem cell graft rejection.

Because ex vivo rapamycin generates murine Th2 cells that prevent Graft-versus-host disease more potently than control Th2 cells, we hypothesized that rapamycin would generate Th2/Tc2 cells (Th2/Tc2.R cells) that abrogate fully MHC-disparate hemopoietic stem cell rejection more effectively than control Th2/Tc2 cells. In a B6-into-BALB/c graft rejection model, donor Th2/Tc2.

[Comparative parameters of myelotoxicity in patients treated with simultaneous chemotherapy and radiotherapy or only radiotherapy].

Background: The Modern oncological treatment usually consists of the different kind of the therapies. Improvement of survival and local control of disease could be possible with combined treatments: surgery, radiotherapy, chemotherapy, etc. However if these treatments are given concomitantly one can expect higher toxicity.

[Multiple neoplasms].

This paper describes observation on multiple carcinomas, with emphasis on double carcinomas of the lungs and other organs. The paper presents four cases of multiple neoplasmas and goes on to discuss eventual etiopathogenesis of multiple malignancies. Of the four cases presented in this paper, three cover double carcinoma of the throat and lungs, and in the fourth, double carcinoma of the lung and bladder.